Unraveling the mechanism by which Rps26-deficient ribosomes form to support the stress response
Unraveling the mechanism by which Rps26-deficient ribosomes form to support the stress response
批准号:
10604511
负责人:
Jason Yoon-Mo Yang
金额:
$1.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2022-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Recently ribosome subpopulations that differ in their composition, lacking individual ribosomal proteins (RPs),
or containing specific modifications have garnered a lot of interest. In the case of RP content, multiple studies
have shown that ribosomes lacking specific RPs are present in cells, including ribosomes deficient in Rps26.
While their physiological relevance remains unclear in most cases, the Karbstein lab has recently
demonstrated that ribosomes lacking Rps26 are produced specifically under high salt and pH stress to enable
the preferential translation of mRNAs encoding proteins from the Hog1 and Rim101 pathways that are required
for the response to these stresses. This change in mRNA specificity between Rps26-containing and deficient
ribosomes arises from the recognition of the -4 position of the Kozak sequence by Rps26, thereby supporting
the translation of well-translated mRNAs by Rps26-containing ribosomes in rich medium, and the translation of
specific mRNAs in the Hog1 and Rim101 pathways by Rps26-deficient ribosomes that are formed under these
stresses.
What remains unknown is how Rps26-deficient ribosomes form under high salt and high pH stress. My
preliminary results suggest Rps26-deficient ribosomes are produced by release of Rps26 from pre-existing
ribosomes. Therefore, I will further dissect in more detail the mechanism that leads to the production of Rps26-
deficient ribosomes, exploring the role of the Rps26-specific chaperone Tsr2 in delivering to and extracting
Rps26 from ribosomes (Aim1), and testing which posttranslational modifications regulate this pathway (Aim2).
Next, I will test if Rps26 is (re-) incorporated into Rps26-deficient ribosomes, to allow for a rapid switch in
mRNA-specificity without the costs of re-building new ribosomes, or whether instead these ribosomes are
degraded (Aim3).
Together, these experiments will clarify how Rps26-deficient ribosomes form under stress. In addition to further
expanding on this novel paradigm of stress-induced production of a specific ribosome population, the results
will also have implications for the development of diseases linked to Rps26-deficiency, such as Diamond-
Blackfan anemia. Because the etiology of 10-15% of all cases remains unknown, and is not linked to RP-
deficiency, it is possible that overactivation of pathways leading to the release of RPs such as Rps26 might be
responsible for a subset of cases, similar to the subset of cases caused by deficiency of the Rps26-chaperone
Tsr2. Furthermore, ribosomes lacking individual RPs, including Rps26, are produced in cancer cells, where
they are associated with poor outcomes. Thus, this work will also help delineate how cancer cells modulate the
translational machinery to subvert translation to its purposes.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1126/sciadv.abl4386
发表时间:
2022-02-25
期刊:
Science advances
影响因子:
13.6
作者:
[Yang YM, Karbstein K]
通讯作者:
Karbstein K
Unraveling the mechanism by which Rps26-deficient ribosomes form to support the stress response
-
批准号:10226865
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2020
-
负责人:Jason Yoon-Mo Yang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位: